-

CALL US AT

( +1 ) 877-441-4866


Get a Call from us

call-icon
Hematology Market

Global Hematology Market – Size, Share and Forecast ( 2019-2026 )

SKU: DMD71 | Last Updated On: 2019-04-09 | No. of Pages: 185 | Available Formats

( 26 Samples have been requested. )
In April 2019, Bio-Rad Laboratories received 510(k) clearance from the US FDA for IH-500, an automated random-access system for blood typing and screening.

Hematology Market

Hematology is a branch of medicine, which deals with the diagnosis, treatment, and prevention of blood, blood-forming organs, and blood diseases such as blood cancer, anemia, hemophilia, and blood clots. Hematological tests constitute in vitro diagnostic techniques such as hemostasis, molecular diagnostics, histology, blood analysis, and flow cytometry and help to identify various blood-related diseases at lower costs. Hematology includes the problems with the red blood cells, white blood cells, platelets and organs that are fed by blood cells, including the lymph nodes, spleen, thymus, and lymphoid tissue. The specialists use the hematology instruments for testing and determining plasma drug levels, for both therapeutic and illicit drugs.


According to the World Health Organization (WHO), around 75% of total births all over the world are affected by hemoglobin and sickle cell trait and affects one in every 12 African Americans every year. Around 70% of all sickle-cell affected births occur in Africa. Furthermore, as per WHO, in 2018, the prevalence of anemia in children is around 45% and 12% in men, and it is increasing rapidly all over the world. According to the National Institute of Health (NIH), anemia affects 30% of women with reproductive age and 40% of pregnant women, worldwide.

The global hematology market was worth $XX million in 2018 and is forecasted to reach $XX million by 2026, at a CAGR of 4.63% during the forecast period.


Global Hematology Market Drivers

The major drivers fueling the growth of the market are a rise in the prevalence of blood disorders, technological advancements such as the introduction of new technically advanced fully automated hematology analyzers and rising R&D expenditure.


Blood disorders are expected to increase with a rapid pace in the near future. According to WHO, hemophilia affects one in 5,000 male births in the US, every year around 400 babies are born with hemophilia. Venous thromboembolism affects around seven million people worldwide and it is a major cause of death in adults. Approximately every two minutes, one person in the world is diagnosed with a type of blood cancer. Hence the burden of blood disorders is increasing with each year.

Major companies are working on making devices easier to use. Technological advancements like hemoglobinometers, that is a pocket-sized compact device and has patient data stored in it and has printable features. Many of the companies are developing a combined hematology and CPR system to improve functionality and features. The development of small and compact systems with high accuracy is increasing such as CELL-DYN series from Abbott.



Global Hematology Market Restraints

Product recalls slow technology adoption and regulatory and reimbursement concerns are going to restrain the market in the forecast period.


Manufacturing glitches of products lead to recall, for instance in April 2017, Sysmex has recalled around 3,682 XN Series Automated Hematology Analyzers, due to raised concerns for flames due to improper alignment of an internal protective sheet that protects electronic components from salty reagents.


Global Hematology Market Segmentation

The global hematology market can be segmented by hematology as Instruments and Reagents. Instruments are further classified as Analyzers and Other Instruments. Other instruments are further segmented as Hemoglobinometers, Flow Cytometers, Centrifuges and Slide Stainer. Reagents are further classified as Hematology Reagents, Stains and Flow Cytometry reagents. By Hemostasis the market is segmented as Instruments and Reagents. Reagents are further classified as Coagulation Reagents and Control Plasmas. By end users, the market is classified as Hospitals, Clinical testing laboratories/ Diagnostic centers and Others.


Hematology analyzers are mainly used in cell counts and differential leukocyte analysis. These are used in the screening and diagnosis of many disease states. Hematology analyzers dominated the market in 2018 with a share of more than 90% due to high technological advancements. Current hematology analyzers are able to provide around seven parts of differential white-cell analysis, based on the different technologies. Advanced technologies of analyzers are developed which reduce manual steps and minimize errors. Heska offers Element HT5 Hematology Analyzer for veterinary use. Heska also offers HemaTrue Veterinary Hematology Analyzer that delivers accurate results in only 55 seconds and with only 20 µL or about one drop of blood.


Hematology reagents are essential for clinical and medical research, especially in cytology to provide accurate results. The market of hematology reagents is expected to grow over the forecast period with a CAGR of 7%. The growth in the market is due to the continuous development of new products and technology like Diagon develops and manufactures hematology reagents for Abbott Laboratories in Hungary. Neomedica d.o.o. offers hematology reagents for Abbot, ABX Horiba, Beckman Coulter, Sysmex, Diatron and also Phoenix Series Hematology Reagents for Phoenix NCC 2310, NCC 1211, and NCC 5500.


Global Hematology Market Geographical Analysis

Geographically, the global Hematology market is divided into North America, Europe, South America, Asia-Pacific and the Middle East and Africa.


North America accounted for majority share within the global hematology market in the year 2018 with more than 30%. The region consists of developed countries such as the United States and Canada, which calls for highly sophisticated products with increased productivity and quicker response times. There are also high incidences of blood cancers, according to Leukemia and Lymphoma Society (LLS) in 2015, around 9.8% of the population in the United States was diagnosed with leukemia, lymphoma, and myeloma.


Asia-Pacific consists of a significant portion of the global population and has a growing prevalence of blood diseases which has seen a rise in demand for hematology devices. Presence of hematology companies in the area, increasing healthcare awareness among the general public, and the desire for superior quality products that produce accurate results are driving the hematology market growth. Asia-Pacific held a significant portion of the market with more than 30% of the total market share in 2018 and is expected to grow at the highest CAGR of 8.21% over the period of forecast. Companies in the region have a robust product lineup for commercial markets, forming partnerships & alliances with local suppliers and improving the existing products, like in March 2016, Mindray Medical International announced a merger with Excelsior Union Limited to expand its product portfolio and market reach. 


Global Hematology Market Competitive Analysis

Some of the major market players are Abbott Laboratories, Sysmex Corporation, Danaher Corporation, Siemens Healthcare, Sigma Aldrich Corporation, Drucker Diagnostics, Bio-Rad Laboratories, Roche Diagnostics, Mindray Medical International Limited and Horiba Ltd.


The top competitors in the global Hematology market are Sysmex Corporation, Beckman Coulter and Horiba and account for more than 90% of the market. The majority of the company’s manufacturing units are based in the Asia Pacific region. The established as well as emerging companies are increasingly focusing on the launch of advanced products to expand their market share.


In June 2018, Beckman Coulter Diagnostics announced a partnership with the University of California to accelerate research measures in the healthcare field and come up with innovative commercial products in the field of hematology.

In May 2018, Beckman Coulter launched DxH 900 hematology analyzer that performs complete blood count and white blood cell differential tests with minimal repeats for application in mid- to high-volume clinical laboratories.


In March 2018, FDA approved Cobas m 511 integrated hematology analyzer developed by Cobas and Roche Diagnostics Hematology, Inc. the system integrates a digital morphology analyzer, cell counter, and classifier into one streamlined instrument preparing, staining, and analyzing microscopy blood slides.

In February 2018, Horiba launched Yumizen G range of semi-automatic to fully automatic hemostasis solutions that suites to any laboratory.

In January 2018, Abbott launched Alinity h-series integrated hematology system, that integrates its Alinity HQ with the Alinity hs slide maker and stainer module into a combined solution.


Why purchase the report?

  • Visualize the composition of the hematology market across each indication, in terms of type and by type highlighting the key commercial assets and players.
  • Identify commercial opportunities in hematology by analyzing trends and co-development deals.
  • Excel data sheets with thousands of data points of hematology market- level 4/5 segmentation.
  • PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
  • Product mapping in excel for the key products of all major market players.


Target Audience:

  • Medical device companies
  • Hospitals and clinics
  • Research and consulting firms
  • Healthcare associations/institutes
  • Venture capitalists
  • Government agencies

Global Hematology Market

1. Hematology Market Methodology and Scope

1.1 Research Methodology

1.2 Research Objective and Scope of the Report

2. Hematology Market – Market Definition and Overview

3. Hematology Market – Executive Summary

3.1 Market Snippet by Hematology

3.2 Market Snippet by Hemostasis

3.3 Market Snippet by End User

3.4 Market Snippet by Region

3.5 DataM CLO Scenario

4. Hematology Market – Market Dynamics

4.1 Market Impacting Factors

4.1.1 Drivers

4.1.1.1 New product developments

4.1.1.2 Increased investments

4.1.1.3 Rising benefits of hematology systems

4.1.2 Restraints

4.1.2.1 Product recalls

4.1.2.2 Slow technological adoption

4.1.2.3 Regulatory and reimbursement concerns

4.1.3 Opportunity

4.1.4 Impact Analysis

5. Hematology Market – Industry Analysis

5.1. Porter's Five Forces Analysis

5.2. Supply Chain Analysis

5.3. Regulatory Analysis

5.4. Epidemiology

6. Hematology Market – By Haematology

6.1. Introduction

6.1.1  Market Size Analysis, and Y-o-Y Growth Analysis (%), By Haematology Segment

6.1.2 Market Attractiveness Index, By Haematology Segment

6.2. Instruments

6.2.1. Introduction

6.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)

6.2.2.1 Analyzers

6.2.2.2 Other Instruments

6.2.2.2.1 Hemoglobinometers

6.2.2.2.2 Flow Cytometers

6.2.2.2.3 Centrifuges

6.2.2.2.4 Slide Stainer

6.3. Reagents

6.3.1 Hematology Reagents

6.3.2 Stains

6.3.3 Flow Cytometry Reagents

7. Hematology Market – By Haemostasis

7.1. Introduction

7.1.1 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Haemostasis Segment

7.1.2 Market Attractiveness Index, By Haemostasis Segment

7.2. Instruments

7.2.1 Introduction

7.2.2 Market Size Analysis, and Y-o-Y Growth Analysis (%)

7.3. Reagents

7.3.1 Coagulation Reagents

7.3.2 Control Plasmas 

8. Hematology Market – By End User

8.1. Introduction

8.1.1 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

8.1.2 Market Attractiveness Index, By End User

8.2. Hospitals

8.1.3 Introduction

8.1.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026

8.3. Clinical testing laboratories/Diagnostic centers

9. Hematology Market – By Region

9.1.Introduction

9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region

9.1.2. Market Attractiveness Index, By Region

9.2. North America

9.2.1 Introduction

9.2.2 Key Region-Specific Dynamics

9.2.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Haematology

9.2.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Haemostasis

9.2.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-users

9.2.6 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

9.2.6.1 U.S.

9.2.6.2 Canada

9.2.6.3 Mexico

9.3. Europe

9.3.1 Introduction

9.3.2 Key Region-Specific Dynamics

9.3.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Haematology

9.3.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Haemostasis

9.3.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-users

9.3.6 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

9.3.6.1 Germany

9.3.6.2 U.K.

9.3.6.3 France

9.3.6.4 Italy

9.3.6.5 Spain

9.3.6.6 Rest of Europe

9.4. South America

9.4.1 Introduction

9.4.2 Key Region-Specific Dynamics

9.4.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Haematology

9.4.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Haemostasis

9.4.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-users

9.4.6 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

9.4.6.1 Brazil

9.4.6.2 Argentina

9.4.6.3 Rest of South America

9.5. Asia Pacific

9.5.1 Introduction

9.5.2 Key Region-Specific Dynamics

9.5.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Haematology

9.5.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Haemostasis

9.5.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-users

9.5.6 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

9.5.6.1 China

9.5.6.2 India

9.5.6.3 Japan

9.5.6.4 Australia

9.5.6.5 Rest of Asia Pacific

9.6. Middle East and Africa

9.6.1 Introduction

9.6.2 Key Region-Specific Dynamics

9.6.3 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Haematology

9.6.4 Market Size Analysis, and Y-o-Y Growth Analysis (%), By Haemostasis

9.6.5 Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-users

10. Hematology Market – Competitive Landscape

10.1. Competitive Scenario

10.2. Competitor Hematology Strategy Analysis

10.3. Comparative Product Portfolio Analysis

10.4. Market Positioning/Share Analysis

10.5. Mergers and Acquisitions Analysis

11. Hematology Market – Company Profiles

11.1. Abbott Laboratories *

11.1.1 Company Overview

11.1.2 Product Portfolio and Description

11.1.3 Key Highlights

11.1.4 Financial Overview

11.2. Sysmex Corporation

11.3. Danaher Corporation

11.4. Siemens Healthcare

11.5. Sigma Aldrich Corporation

11.6. Drucker Diagnostics

11.7. Bio-Rad Laboratories

11.8. Roche Diagnostics

11.9. Mindray Medical International Ltd

11.10. Horiba Ltd

12. Global Hematology Market – Premium Insights

13. Global Hematology Market – DataM

13.1. Appendix

13.2. About Us and Services

13.3. Contact Us

Buy This Report



INSTANT DELIVERY - 20% OFF

Could not find what you need?

Quick Fact: 7 of 10 customers Tailor their reports